Pacific Biosciences Of California Revenue 2012-2025 | PACB
Pacific Biosciences Of California revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Pacific Biosciences Of California Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $154 |
| 2023 | $201 |
| 2022 | $128 |
| 2021 | $131 |
| 2020 | $79 |
| 2019 | $91 |
| 2018 | $79 |
| 2017 | $93 |
| 2016 | $91 |
| 2015 | $93 |
| 2014 | $61 |
| 2013 | $28 |
| 2012 | $26 |
| 2011 | $34 |
|
Pacific Biosciences Of California Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $38 |
| 2025-06-30 | $40 |
| 2025-03-31 | $37 |
| 2024-12-31 | $39 |
| 2024-09-30 | $40 |
| 2024-06-30 | $36 |
| 2024-03-31 | $39 |
| 2023-12-31 | $58 |
| 2023-09-30 | $56 |
| 2023-06-30 | $48 |
| 2023-03-31 | $39 |
| 2022-12-31 | $27 |
| 2022-09-30 | $32 |
| 2022-06-30 | $35 |
| 2022-03-31 | $33 |
| 2021-12-31 | $36 |
| 2021-09-30 | $35 |
| 2021-06-30 | $31 |
| 2021-03-31 | $29 |
| 2020-12-31 | $27 |
| 2020-09-30 | $19 |
| 2020-06-30 | $17 |
| 2020-03-31 | $16 |
| 2019-12-31 | $28 |
| 2019-09-30 | $22 |
| 2019-06-30 | $25 |
| 2019-03-31 | $16 |
| 2018-12-31 | $20 |
| 2018-09-30 | $18 |
| 2018-06-30 | $22 |
| 2018-03-31 | $19 |
| 2017-12-31 | $25 |
| 2017-09-30 | $24 |
| 2017-06-30 | $20 |
| 2017-03-31 | $25 |
| 2016-12-31 | $26 |
| 2016-09-30 | $25 |
| 2016-06-30 | $21 |
| 2016-03-31 | $19 |
| 2015-12-31 | $36 |
| 2015-09-30 | $14 |
| 2015-06-30 | $25 |
| 2015-03-31 | $18 |
| 2014-12-31 | $17 |
| 2014-09-30 | $21 |
| 2014-06-30 | $11 |
| 2014-03-31 | $12 |
| 2013-12-31 | $9 |
| 2013-09-30 | $7 |
| 2013-06-30 | $6 |
| 2013-03-31 | $6 |
| 2012-12-31 | $6 |
| 2012-09-30 | $3 |
| 2012-06-30 | $7 |
| 2012-03-31 | $10 |
| 2011-12-31 | $12 |
| 2011-09-30 | $11 |
| 2011-06-30 | $11 |
| 2011-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.667B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Alcon (ALC) | Switzerland | $0.000B | 26.33 |